Skip to main content
. Author manuscript; available in PMC: 2010 Oct 20.
Published in final edited form as: Prostate. 2008 Sep 15;68(13):1416–1420. doi: 10.1002/pros.20797

Table 3.

Relative Risks (RR) and 95% confidence intervals (CI) for the association between IRS-1 Gly972Arg variant and prostate cancer

Cases, n RR (95% CI)

All prostate cancer
   GG 489 1.0 (Ref)
   GA/AA 75 1.1 (0.8, 1.5)
Tumor stage
A/B
   GG 266 1.00
   GA/AA 37 0.9 (0.6, 1.4)
C, D or lethal
   GG 188 1.00
   GA/AA 31 1.3 (0.8, 2.3)